Urinary Bladder Neoplasms
"Urinary Bladder Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the URINARY BLADDER.
Descriptor ID |
D001749
|
MeSH Number(s) |
C04.588.945.947.960 C12.758.820.968 C12.777.829.813 C13.351.937.820.945 C13.351.968.829.707
|
Concept/Terms |
Urinary Bladder Neoplasms- Urinary Bladder Neoplasms
- Neoplasm, Urinary Bladder
- Urinary Bladder Neoplasm
- Neoplasms, Bladder
- Bladder Neoplasms
- Bladder Neoplasm
- Neoplasm, Bladder
- Bladder Tumors
- Bladder Tumor
- Tumor, Bladder
- Tumors, Bladder
Urinary Bladder Cancer- Urinary Bladder Cancer
- Cancer, Urinary Bladder
- Malignant Tumor of Urinary Bladder
- Cancer of the Bladder
- Bladder Cancer
- Bladder Cancers
- Cancer, Bladder
- Cancer of Bladder
|
Below are MeSH descriptors whose meaning is more general than "Urinary Bladder Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Urinary Bladder Neoplasms".
This graph shows the total number of publications written about "Urinary Bladder Neoplasms" by people in this website by year, and whether "Urinary Bladder Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
2004 | 2 | 0 | 2 |
2005 | 3 | 1 | 4 |
2007 | 3 | 0 | 3 |
2009 | 3 | 0 | 3 |
2010 | 4 | 0 | 4 |
2011 | 1 | 0 | 1 |
2012 | 8 | 0 | 8 |
2013 | 4 | 0 | 4 |
2014 | 2 | 0 | 2 |
2015 | 5 | 0 | 5 |
2016 | 7 | 1 | 8 |
2017 | 79 | 8 | 87 |
2018 | 103 | 6 | 109 |
2019 | 45 | 2 | 47 |
2020 | 7 | 2 | 9 |
2021 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Urinary Bladder Neoplasms" by people in Profiles.
-
Autoimmune hepatitis triggered by SARS-CoV-2 vaccination. J Autoimmun. 2021 09; 123:102710.
-
Impact of delay in cystoscopic surveillance on recurrence and progression rates in patients with non-muscle-invasive bladder cancer during the COVID-19 pandemic. Int J Clin Pract. 2021 Sep; 75(9):e14490.
-
A prospective observational study on oral administration of Ellagic Acid and Annona Muricata in patients affected by non-muscle invasive bladder cancer not undergoing maintenance after 6-week intravesical prophylaxis. Urologia. 2022 Feb; 89(1):49-52.
-
Urinary biomarkers to mitigate diagnostic delay in bladder cancer during the COVID-19 era. Nat Rev Urol. 2021 04; 18(4):185-187.
-
Protective role of intravesical BCG in COVID-19 severity. BMC Urol. 2021 Mar 30; 21(1):50.
-
Oncology and complications. Arch Ital Urol Androl. 2021 Mar 19; 93(1):71-76.
-
Effect of Coronavirus Disease 2019 on Patients with Bladder Cancer in China. Urol Int. 2021; 105(7-8):726-728.
-
Delivering safe and timely cancer care during COVID-19: lessons and successes from the transition period. BJU Int. 2021 06; 127(6):633-635.
-
How uro-oncology has been affected by COVID-19 emergency? Data from Piedmont/Valle d'Aosta Oncological Network, Italy. Urologia. 2021 Feb; 88(1):3-8.
-
Safety and Efficacy of Transurethral Resection of Bladder Tumor Comparing Spinal Anesthesia with Spinal Anesthesia with an Obturator Nerve Block: A Systematic Review and Meta-analysis. J Endourol. 2021 03; 35(3):249-258.